Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double-blind, Placebo-controlled Clinical Trial to Evaluate the to Assess the Efficacy of Intravenous Metoprolol in Patients With Acute Respiratory Distress Syndrome (ARDS).

NCT05847517 is registered in ClinicalTrials.gov with Consorcio Centro de Investigación Biomédica en Red (CIBER) as lead sponsor.

NCT NCT05847517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05847517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double-blind, Placebo-controlled Clinical Trial to Evaluate the to Assess the Efficacy of Intravenous Metoprolol in Patients With Acute Respiratory Distress Syndrome (ARDS).
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase
Phase 3
Overall status
Terminated
Start date
July 10, 2024
Completion date
October 6, 2025
Enrollment
14 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome (ards)